TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material | Modern Pathology
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations - ScienceDirect
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Figure 2 from Improved lung cancer classification using new optimized immunohistochemical assay with anti-p 40 ( BC 28 ) mouse monoclonal antibody | Semantic Scholar
Expression of P40 and P63 in lung cancers using fine needle aspiration cases. Understanding clinical pitfalls and limitations. - Abstract - Europe PMC
The p63 + CK5 antibody - Biocare Medical
Frontiers | Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma | Modern Pathology
Pathology Outlines - p63
The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung | PLOS ONE
Webpathology.com: A Collection of Surgical Pathology Images
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors | Biomarker Research | Full Text
p63 Monoclonal Rabbit Antibody (TP63/1423R) - Biotium
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
p63 (Squamous, Basal & Myoepithelial Cell Marker) Ultraspecific Antibody Tested against >20,000 Human Proteins – enQuire BioReagents
A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix | Diagnostic Pathology | Full Text
Expression of TTF-1, p63 in lung cancer (Envision two-step method,... | Download Scientific Diagram
Immunohistochemistry stains in squamous cell carcinoma and... | Download Scientific Diagram
Subtyping Non–Small Cell Lung Cancer: Relevant Issues and Operative Recommendations for the Best Pathology Practice - Giulio Rossi, Giuseppe Pelosi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Mauro Papotti, 2013
IJMS | Free Full-Text | p63 Is a Promising Marker in the Diagnosis of Unusual Skin Cancer
p63 expression in assessment of bronchioloalveolar proliferations of the lung | Modern Pathology
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens | SpringerLink
